Dear Valued Shareholders
Hello everyone,
Wellgistics Health, Inc. (NASDAQ: WGRX) is proud to update you on our remarkable journey. Over the past year, we transitioned from being a private entity to joining the public sector, listing on the Nasdaq. At the start of this journey, we faced challenges within a pharmaceutical supply chain riddled with inefficiencies and a lack of pricing transparency, impacting independent pharmacies and their stakeholders.
Growth and Achievement in 2024
Today, we are excited to announce the breakthrough measures we've implemented to position Wellgistics Health as a leader in our field. Our pro forma consolidated net sales for the year 2024 have soared to $45.7 million, which represents a significant 33% increase from the previous year. This growth resulted from strategic acquisitions that broaden our service offerings, enabling us to make a more substantial impact across the healthcare landscape.
Introducing Wellgistics Hub
One of our crowning achievements is the creation of the Wellgistics Hub, an AI-enhanced prescription processing platform that aims to simplify the experience for both patients and providers. This system allows providers to process prescriptions through various channels, including in-office visits or telehealth, and offers real-time checks on insurance, potential discounts, and transparent out-of-pocket costs.
Addressing Lack of Affordability
One of the most compelling features of our platform is its ability to facilitate a seamless feedback loop between patients and their healthcare providers. Patients who face affordability dilemmas can leverage the Wellgistics Hub app to inquire about more cost-effective alternative medications, addressing a significant issue in healthcare where nearly 30% of written prescriptions go unfilled due to financial barriers.
Enhancing Pharmacy Collaboration
Our fulfillment network is powered by a robust network of over 5,000 independent pharmacies, a figure we aim to significantly expand through new partnerships with group purchasing organizations (GPOs). This partnership not only improves operational efficiency for pharmacies but also enhances access to a wide range of medications—both generic and specialized drugs.
Introducing EinsteinRx
We are also thrilled to unveil EinsteinRx, a transformative decision-support software embedded within the Wellgistics Hub. This tool leverages AI-driven analytics to improve prescription routing early in the process, considering patient demographics, pharmacy capabilities, and therapeutic options in real-time. As EinsteinRx further evolves, we anticipate that it will become increasingly adaptive, refining how we handle prescription feedback and routing.
Unique Market Proposition
What truly differentiates Wellgistics Health is our proprietary technology that allows healthcare providers to become ambassadors for our services. Unlike traditional costly marketing strategies, we reduce administrative burdens on pharmacists, enabling them to focus on enhancing patient outcomes while engaging them consistently throughout their healthcare journey.
Strategic Growth Plans
As we build our market share, we have laid out clear paths for future profitability:
- SaaS Expansion: By onboarding 5,000 new pharmacies by mid-2026, we anticipate a significant increase in our recurring revenue stream.
- Patient Growth: We are aiming for a tenfold increase in our active patient base by year-end, displaying a growing demand for accessible prescription services.
- Distribution Efficiency: Our integrated platform is designed to cut unnecessary costs by removing intermediaries, allowing for fair pricing across the board.
Looking Ahead
In the coming months, our priorities will concentrate on:
- Completing technology-driven acquisitions to broaden our infrastructure.
- Launching innovative predictive care AI services within the Wellgistics Tech & Hub Services division.
- Strengthening our integration with employers and healthcare plan providers to enhance price transparency.
Why Our Mission Matters
The U.S. suffers from exorbitant costs linked to not adhering to prescribed medications, with estimates exceeding $300 billion yearly. We strongly believe these challenges arise not from individual patient behaviors but rather from systemic failures—such as delays in authorizations and lack of clear pricing information at the pharmacy level.
The ongoing struggle for patients to understand their medication costs often results in an abandonment rate significantly higher when faced with large co-pays, further intensifying our healthcare system's financial burdens. Wellgistics Health is uniquely positioned to address these issues through innovation and collaboration.
Final Reflections
As we reflect on the past year, it’s clear that we have laid a solid foundation for the future. Anticipating the market shift from fee-for-service to value-based care, our commitment to revolutionizing prescription access is more critical than ever.
Thank you for your unwavering support as we work toward reimagining healthcare in America. Together, we are embarking on an essential journey toward transparency and access.
Warm regards,
Brian Norton
Chief Executive Officer
Wellgistics Health
Frequently Asked Questions
What are the primary services offered by Wellgistics Health?
Wellgistics Health specializes in prescription processing and pharmaceutical distribution, enhancing patient and provider experiences through AI-driven technology.
How does Wellgistics Health improve prescription affordability?
The Wellgistics Hub allows for transparency in medication costs and helps patients find alternative medicines if financial barriers arise.
What is the significance of EinsteinRx?
EinsteinRx is a decision support system that optimizes prescription routing and enhances medication access using real-time data analytics.
How is Wellgistics Health positioning itself in the market?
By focusing on reducing administrative burdens on pharmacies and engaging healthcare providers, Wellgistics Health is creating strong market defensibility.
What are the anticipated outcomes for Wellgistics Health in the coming year?
We aim to expand our pharmacy network, increase our patient base significantly, and launch new technology-driven services aimed at improving healthcare access and affordability.
